Prdm16 is required for normal palatogenesis in mice

被引:103
作者
Bjork, Bryan C. [1 ]
Turbe-Doan, Annick [1 ]
Prysak, Mary [1 ]
Herron, Bruce J. [1 ]
Beier, David R. [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
PIERRE-ROBIN-SEQUENCE; MYELOID-TRANSFORMING GENE; SYNDROMIC CLEFT-PALATE; CRANIAL NEURAL CREST; PR DOMAIN; MANDIBULAR DEVELOPMENT; TRANSCRIPTIONAL CONTROL; CONSENSUS SEQUENCE; GROWTH-INHIBITION; SECONDARY PALATE;
D O I
10.1093/hmg/ddp543
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transcriptional cofactors are essential to the regulation of transforming growth factor beta (TGF beta) superfamily signaling and play critical and widespread roles during embryonic development, including craniofacial development. We describe the cleft secondary palate 1 (csp1) N-ethyl-N-nitrosourea-induced mouse model of non-syndromic cleft palate (NSCP) that is caused by an intronic Prdm16 splicing mutation. Prdm16 encodes a transcriptional cofactor that regulates TGF beta signaling, and its expression pattern is consistent with a role in palate and craniofacial development. The cleft palate (CP) appears to be the result of micrognathia and failed palate shelf elevation due to physical obstruction by the tongue, resembling human Pierre Robin sequence (PRS)-like cleft secondary palate. PRDM16 should be considered a candidate for mutation in human clefting disorders, especially NSCP and PRS-like CP.
引用
收藏
页码:774 / 789
页数:16
相关论文
共 74 条
  • [31] Kosazuma Tsuneo, 2004, Congenital Anomalies, V44, P60, DOI 10.1111/j.1741-4520.2004.00010.x
  • [32] LOSS OF ERYTHROPOIETIN RESPONSIVENESS IN ERYTHROID PROGENITORS DUE TO EXPRESSION OF THE EVI-1 MYELOID-TRANSFORMING GENE
    KREIDER, BL
    ORKIN, SH
    IHLE, JN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) : 6454 - 6458
  • [33] The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3
    Kurokawa, M
    Mitani, K
    Irie, K
    Matsuyama, T
    Takahashi, T
    Chiba, S
    Yazaki, Y
    Matsumoto, K
    Hirai, H
    [J]. NATURE, 1998, 394 (6688) : 92 - 96
  • [34] The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-β-mediated growth inhibition of myeloid cells
    Kurokawa, M
    Mitani, K
    Imai, Y
    Ogawa, S
    Yazaki, Y
    Hirai, H
    [J]. BLOOD, 1998, 92 (11) : 4003 - 4012
  • [35] Threshold-specific requirements for Bmp4 in mandibular development
    Liu, W
    Selever, J
    Murali, D
    Sun, XX
    Brugger, SM
    Ma, LJ
    Schwartz, RJ
    Maxson, R
    Furuta, Y
    Martin, JF
    [J]. DEVELOPMENTAL BIOLOGY, 2005, 283 (02) : 282 - 293
  • [36] TBX22 mutations are a frequent cause of cleft palate
    Marçano, ACB
    Doudney, K
    Braybrook, C
    Squires, R
    Patton, MA
    Lees, MM
    Richieri-Costa, A
    Lidral, AC
    Murray, JC
    Moore, GE
    Stanier, P
    [J]. JOURNAL OF MEDICAL GENETICS, 2004, 41 (01) : 68 - 74
  • [37] Transcriptional control by the TGF-β/Smad signaling system
    Massagué, J
    Wotton, D
    [J]. EMBO JOURNAL, 2000, 19 (08) : 1745 - 1754
  • [38] DIFFERENT PHENOTYPES FOR MICE DEFICIENT IN EITHER ACTIVINS OR ACTIVIN RECEPTOR-TYPE-II
    MATZUK, MM
    KUMAR, TR
    BRADLEY, A
    [J]. NATURE, 1995, 374 (6520) : 356 - 360
  • [39] Epidermal growth factor receptor function is necessary for normal craniofacial development and palate closure
    Miettinen, PJ
    Chin, JR
    Shum, L
    Slavkin, HC
    Shuler, CF
    Derynck, R
    Werb, Z
    [J]. NATURE GENETICS, 1999, 22 (01) : 69 - 73
  • [40] Miletich Isabelle, 2004, Birth Defects Res C Embryo Today, V72, P200, DOI 10.1002/bdrc.20012